Upgrade to SI Premium - Free Trial

Medtronic, Inc. (MDT) PT Lowered to $92 at BMO Capital on 1Q18 Report; 'Tricky Quarter, Tricky Guidance'

August 23, 2017 9:10 AM
BMO Capital lowered its price target on Medtronic, Inc. (NYSE: MDT) to $92.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles